IGB Fox Family Innovation and Entrepreneurship Lecture Series on Tuesday, October 30
10/26/2018 4:17:32 PM
Dr. David Kranz joined the faculty of the Department of Biochemistry in 1987, where his research program focuses on immunology. His specific interest is in the structure, function, and engineering of T cell receptors. Kranz is an inventor on 16 issued US patents and many international patents. In the past 15 years, he co-founded two of the most successful start-up companies originating from work at the University of Illinois, BioDisplay and ImmuVen. BioDisplay was acquired by Abbott Laboratories in 2002 and ImmuVen was acquired by AbbVie in 2014.
The IGB is excited to host Dr. Kranz’s talk, “Biotechnology Companies & the Rise of Cancer Immunotherapies” and look forward to you joining us.